EcoDrugPlus

Telomerase Reverse Transcriptase

Ensembl ID : ENSODEG00000018274
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSODEG00000013240
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSODEG00000013384
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSODEG00000016624
Gene Symbol: TYMP
3 Cross references
173 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSODEG00000006402
Gene Symbol: TYMS
2 Cross references
222 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSODEG00000002741
Gene Symbol: THRB
3 Cross references
392 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSODEG00000003343
Gene Symbol: TRHR
3 Cross references
266 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSODEG00000004825
Gene Symbol: TLR4
3 Cross references
127 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSODEG00000003661
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 9

Ensembl ID : ENSODEG00000018236
Gene Symbol: TLR9
3 Cross references
82 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSODEG00000003331
Gene Symbol: TGFBR1
3 Cross references
230 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSODEG00000004465
Gene Symbol: TRPA1
3 Cross references
226 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).